Pleural mesothelioma: Little evidence, still time to do trials

Lancet

Volumn 364, Issue 9440, 2004, Pages 1183-1185

  Treasure, Prof Tom ^a   Sedrakyan, Artyom ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYANOCOBALAMIN; DOXORUBICIN; FOLIC ACID; PEMETREXED;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DYSPNEA; EXTRAPLEURAL PNEUMONECTOMY; HUMAN; INCIDENCE; LUNG RESECTION; PLEURA MESOTHELIOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; THORAX WALL;

EID: 4644362833     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17108-0     Document Type: Short Survey

References (34)

1. Montanaro F, Bray F, Gennaro V, et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control. 14:2003;791-803
2. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med. 61:2004;438-441
3. Abratt RP, Vorobiof DA, White N. Asbestos and mesothelioma in South Africa. Lung Cancer. 45:(suppl 1):2004;S3-6
4. Musk AW, De Klerk NH. Epidemiology of malignant mesothelioma in Australia. Lung Cancer. 45:(suppl 1):2004;S21-23
5. Health and Safety Executive. Asbestos-related diseases: mesothelioma. Jan 27, 2004: http://www.hse.gov.uk/statistics/causdis/meso.htm (accessed Aug 16, 2004).
6. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 44:2000;565-601
7. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 79:1999;666-672
8. van Klaveren RJ, Aerts JG, de Bruin H, Giaccone G, Manegold C, van Meerbeeck JP. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer. 43:2004;63-69
9. Monetti F, Casanova S, Grasso A, Cafferata MA, Ardizzoni A, Neumaier CE. Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer. 43:2004;71-74
10. Berghmans T, Paesmans M, Lalami Y, et al. Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer. 38:2002;111-121
11. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 21:2003;2636-2644
12. Muers MF, Rudd RM, O'Brien ME, et al. BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma. Thorax. 59:2004;144-148
13. National Cancer Research Networks (NCRN). Trials portfolio: mesothelioma trials. Jan 21, 2003: http://www.ncrn.org.uk/portfolio/summary.asp?DiseaseID= 27&Status=34&type=0&GroupID=8 (accessed Aug 16, 2004).
14. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004: CD002916.
15. van Ruth S, Baas P, Zoetmulder FA. Surgical treatment of malignant pleural mesothelioma: a review. Chest. 123:2003;551-561
16. Tan C, Swift S, Gilham C, et al. Survival in surgically diagnosed patients with malignant mesothelioma in current practice. Thorax 2002; 57 (suppl iii): iii36 (abstr).
17. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 68:1999;1799-1804
18. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 117:1999;54-63
19. Ceresoli GL, Locati LD, Ferreri AJ, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 34:2001;79-87
20. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg. 22:2002;298-305
21. van Ruth S, Baas P, Haas RL, Rutgers EJ, Verwaal VJ, Zoetmulder FA. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma. Ann Surg Oncol. 10:2003;176-182
22. Friedberg JS, Mick R, Stevenson J, et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg. 75:2003;952-959
23. Pass HI, Temeck BK, Kranda K, et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 4:1997;628-633
24. Grossebner MW, Arifi AA, Goddard M, Ritchie AJ. Mesothelioma - VATS biopsy and lung mobilization improves diagnosis and palliation. Eur J Cardiothorac Surg. 16:1999;619-623
25. Maggi G, Casadio C, Cianci R, Rena O, Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 19:2001;346-350
26. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 22:2001;788-795
27. Lee TT, Everett DL, Shu HK, et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 124:2002;1183-1189
28. Ahamad A, Stevens CW, Smythe WR, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J. 9:2003;476-484
29. Stewart DJ, Martin-Ucar A, Pilling JE, Edwards JG, O'Byrne KJ, Waller DA. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann Thorac Surg. 78:2004;245-252
30. Sugarbaker DJ, Jaklitsch MT, Bueno R. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 128:2004;138-146
31. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest. 108:1995;754-758
32. Bydder S, Phillips M, Joseph DJ, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer. 91:2004;9-10
33. Graaf-Strukowska L, van der ZJ, van Putten W, Senan S. Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura. Int J Radiat Oncol Biol Phys. 43:1999;511-516
34. Ahamad A, Stevens CW, Smythe WR, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 55:2003;768-775